News / Taiwan / cnyes
Vitalon Medical's August Revenue Jumps 32% YoY
Health Services · Medical/Nursing Services · cnyes · 2026-09-09
4104
Vitalon Medical (4104) reported a strong August revenue of NT$944 million, up 32.25% year-over-year, outperforming the biotech sector index.
What Happened
Revenue Performance: Vitalon Medical (4104) reported August 2026 revenue of NT$944 million, reflecting a 32.25% year-over-year increase and an 11.96% month-over-month growth.
Year-to-Date Growth: Cumulative revenue for the first eight months of 2026 reached NT$6.517 billion, showing a steady year-to-date growth of 13.5%.
Market Context: The stock is currently trading at NT$71, with a slight 0.28% decline over the past five days, outperforming the broader biotech and medical sector index.
Business Scope: The company is primarily engaged in hemodialysis medical consumables, surgical equipment, blood bags, ostomy products, and various health appliances and skincare products.